CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
-8.4%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$4.07B
AUM Growth
-$732M
(-15%)
Cap. Flow
-$330M
Cap. Flow
% of AUM
-8.11%
Top 10 Holdings %
Top 10 Hldgs %
18.03%
Holding
681
New
46
Increased
261
Reduced
260
Closed
64
Top Buys
| 1 |
Nike
NKE
|
+$34.7M |
| 2 |
Starbucks
SBUX
|
+$27.3M |
| 3 |
Procter & Gamble
PG
|
+$26M |
| 4 |
McKesson
MCK
|
+$24M |
| 5 |
NVIDIA
NVDA
|
+$23.9M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
+$109M |
| 2 |
iShares US Real Estate ETF
IYR
|
+$30.4M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$23.6M |
| 4 |
SNI
Scripps Networks Interactive, Inc Common Class A
SNI
|
+$20.3M |
| 5 |
Kellanova
K
|
+$20.3M |
Sector Composition
| 1 | Healthcare | 28.72% |
| 2 | Financials | 13.85% |
| 3 | Technology | 10.07% |
| 4 | Consumer Discretionary | 8.55% |
| 5 | Consumer Staples | 8.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Halozyme
HALO
$8.76B
| $1.74M | 0.04% |
129,600
-13,400
| -9% | -$180K |
|
352
PNC Financial Services
PNC
$80.2B
| $1.73M | 0.04% |
19,407
+3,328
| +21% | +$297K |
|
353
Rogers Communications
RCI
$19.3B
| $1.72M | 0.04% |
50,246
-10,078
| -17% | -$346K |
|
354
Karyopharm Therapeutics
KPTI
$54.2M
| $1.7M | 0.04% |
10,740
+1,873
| +21% | +$296K |
|
355
TC Energy
TRP
$53.9B
| $1.69M | 0.04% |
53,539
+2,569
| +5% | +$80.9K |
|
356
Salesforce
CRM
$240B
| $1.67M | 0.04% |
24,061
-2,672
| -10% | -$186K |
|
|
RTN
357
DELISTED
Raytheon Company
RTN
| $1.67M | 0.04% |
15,267
-19,424
| -56% | -$2.12M |
|
358
Vulcan Materials
VMC
$39.5B
| $1.65M | 0.04% |
+18,545
| New | +$1.65M |
|
|
LNKD
359
DELISTED
LinkedIn Corporation
LNKD
| $1.63M | 0.04% |
8,556
+888
| +12% | +$169K |
|
360
Novavax
NVAX
$1.26B
| $1.62M | 0.04% |
+11,436
| New | +$1.62M |
|
361
Cooper Companies
COO
$13.7B
| $1.61M | 0.04% |
43,160
-8,840
| -17% | -$329K |
|
362
Align Technology
ALGN
$9.92B
| $1.59M | 0.04% |
28,000
+7,000
| +33% | +$397K |
|
|
S
363
DELISTED
Sprint Corporation
S
| $1.59M | 0.04% |
413,144
-28,596
| -6% | -$110K |
|
|
AEGR
364
DELISTED
Aegerion Pharmaceuticals, Inc.
AEGR
| $1.58M | 0.04% |
115,800
+1,800
| +2% | +$24.5K |
|
365
Waste Management
WM
$88.2B
| $1.57M | 0.04% |
31,579
-96,239
| -75% | -$4.79M |
|
366
Deere & Co
DE
$130B
| $1.57M | 0.04% |
21,241
-1,196
| -5% | -$88.5K |
|
367
APA Corp
APA
$7.96B
| $1.55M | 0.04% |
39,652
+1,903
| +5% | +$74.5K |
|
368
Marsh & McLennan
MMC
$100B
| $1.55M | 0.04% |
29,739
+5,789
| +24% | +$302K |
|
|
ZGNX
369
DELISTED
Zogenix, Inc.
ZGNX
| $1.54M | 0.04% |
+113,900
| New | +$1.54M |
|
|
LDRH
370
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
| $1.52M | 0.04% |
44,000
+28,000
| +175% | +$967K |
|
|
OMED
371
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $1.51M | 0.04% |
90,700
+10,700
| +13% | +$178K |
|
|
FPRX
372
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $1.5M | 0.04% |
+97,300
| New | +$1.5M |
|
373
Morgan Stanley
MS
$238B
| $1.49M | 0.04% |
47,141
+6,564
| +16% | +$207K |
|
374
Equity Residential
EQR
$25.4B
| $1.48M | 0.04% |
19,640
+1,515
| +8% | +$114K |
|
|
SRRA
375
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $1.46M | 0.04% |
+1,780
| New | +$1.46M |
|